Ignite Creation Date:
2024-05-06 @ 7:01 PM
Last Modification Date:
2024-10-26 @ 2:58 PM
Study NCT ID:
NCT05861778
Status:
COMPLETED
Last Update Posted:
2023-12-11
First Post:
2023-04-05
Brief Title:
Evaluation of 89Zr-TLX250 PETCT in Chinese Patients With Indeterminate Renal Masses or Suspected Recurrent Renal Clear Cell Carcinoma
Sponsor:
Telix Pharmaceuticals Innovations Pty Limited
Organization:
Telix Pharmaceuticals Innovations Pty Limited
Organization Data
Organization:
Telix Pharmaceuticals Innovations Pty Limited
Class:
INDUSTRY
Study ID:
TLX250CDx-CP-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Telix Pharmaceuticals Innovations Pty Limited
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Grand Pharmaceutical China Co Ltd | OTHER |